Selectivity of F8-Actinomycin D for RNA:DNA hybrids and its anti-leukemia activity

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 6, 1997, Pages 1197-1207

  Takusagawa, Fusao ^a   Takusagawa, Ken T ^a   Carlson, Robert G ^a   Weaver, Robert F ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOMYCIN DERIVATIVE; DACTINOMYCIN; RIBONUCLEASE H;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; CHEMICAL STRUCTURE; CONFERENCE PAPER; CRYSTAL STRUCTURE; DNA RNA HYBRIDIZATION; DRUG ACTIVITY; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ANTINEOPLASTIC AGENTS; DACTINOMYCIN; DNA; DNA-DIRECTED RNA POLYMERASES; HUMANS; LEUKEMIA; NEOPLASMS; NUCLEIC ACID CONFORMATION; NUCLEIC ACID HETERODUPLEXES; RNA; TUMOR CELLS, CULTURED;

EUKARYOTA;

EID: 0030908405     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00062-X     Document Type: Conference Paper

References (33)

1. Perun, T. J.; Propst, C. L. In Nucleic Acid Targeted Drug Design; Propst, C. L.; Perun, T. J., Eds.; Marcel Dekker: New York, 1992; pp 1-12.
2. Wain-Holson, S.; Sonigo, P.; Danos, O.; Cole, S.; Alizon, M. Cell 1985, 40, 9.
3. Swanstorm, R.; Varmus, H. E.; Bishop, J. M. J. Biol. Chem. 1981, 256, 1115.
4. Resnick, R.; Omer, C. A.; Faras, A. J. J. Virol. 1984, 51, 813.
5. Omer, C. A.; Faras, A. J. Cell 1982, 30, 797.
6. Gerard, G. F. Biochemistry 1981, 20, 256.
7. Champoux, J. J.; Gilboa, E.; Baltimore, D. J. Virol. 1984, 49, 686.
8. Verma, I. M. Biochim. Biophys. Acta 1977, 473, 1.
9. Müller, W. E. G.; Zahn, R. K.; Seidel, H. J. Nat. New Biol. 1971, 232, 143.
10. McDonnell, J. P.; Quintrell, N.; Garapin, A.-C.; Fanshier, L.; Levinson, W. E.; Bishop, J. M. Nature (London) 1970, 228, 433.
11. Kamitori, S.; Takusagawa, F. J. Mol. Biol. 1992, 225, 445.
12. Kamitori, S.; Takusagawa, F. J. Am. Chem. Soc. 1994, 116, 4154.
13. Shinomiya, M.; Chu, W.; Carlson, R. G.; Weaver, R. F.; Takusagawa, F. Biochemistry 1995, 34, 8481.
14. Chu, W.; Kamitori, S.; Shinomiya, M.; Carlson, R. G.; Takusagawa, F. J. Am. Chem. Soc. 1994, 116, 2243.
15. Filler, R. In Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications; Filler, R.; Kobayashi, Y.; Yagupolskii, L. M., Eds.; Elsevier: Amsterdam, 1993; pp 1-22.
16. Sobell, H. M.; Jain, S. C. J. Mol. Biol. 1972, 68, 21.
17. Meienhofer, J.; Atherton, E. In Structure-Activity Relationships among the Semisynthetic Antibiotics; Perlman, D., Ed.; Academic: New York, 1977; pp 427-529.
18. Wang, A. H. J.; Fujii, S.; van Boom, J. H.; van der Marel, G. A.; van Boeckel, S. A. A.; Rich, A. Nature (London) 1982, 299, 601.
19. Horton, N. C.; Frinzel, B. C. Am. Cryst. Assoc. Abs. 1995, 23, M099.
20. Dickerson, R. E. Nucl. Acids Res. 1989, 17, 1797.
21. Dickerson, R. E.; Kopka, M. L.; Pjura, P. Chemica Scripta 1986, 26B, 139.
22. Müller, W. Naturwissenschaften 1972, 49, 156.
23. Chu, W.; Shinomiya, M.; Kamitori, K.; Kamitori, S; Carlson, R. G.; Weaver, R. F.; Takusagawa, F. J. Am. Chem. Soc. 1994, 116, 7971.
24. Dixon, D. A.; Smart, B. E. In Selective Fluorination in Organic and Bioorganic Chemistry; Welch, J. T., Ed.; ACS Symposium Series 456, American Chemical Society: Washington, DC, 1991; pp 18-35.
25. Scamrov, A. V.; Beabealashvilli, R. Sh. FEBS Lett. 1983, 164, 97.
26. Tanaka, I.; Yao, M.; Suzuki, M.; Hikichi, K.; Matsumoto, T.; Kozasa, M.; Katayama, C. J. Appl. Cryst. 1990, 23, 334.
27. Takusagawa, F. J. Appl. Cryst. 1992, 25, 26.
28. Brünger, A. T. X-PLOR 3.1. A System for X-ray Crystallography and NMR. Yale University: New Haven, 1993.
29. Jones, T. A. Methods Enzymo. 1985, 115, 157.
30. Cantor, C. R.; Warshaw, M. M. Biopolymer 1970, 9, 1059.
31. Chen, F.-M. Biochemistry 1988, 27, 6393.
32. Chomczynski, P.; Sacchi, N. Anal. Biochem. 1987, 162, 156.
33. Grever, M. R.; Schepartz, S. A.; Chabner, B. A. Seminars in Oncology 1992, 19, 622.